Biostatistician turned PM specializing in AI-enabled clinical trial design. I build 0→1 tools that support protocol strategy, evidence evaluation, and critical program decisions. My approach centers on clear evidence, explicit assumptions, and deliberate architecture to create systems that hold up under real-world complexity and scientific scrutiny.

Currently: Unlearn.AI (San Francisco, CA)
Previously: Dana-Faber Cancer Institute (Boston, MA), Columbia University (New York, NY), Institute for Cancer Research (London, UK), Hospital for Special Surgery (New York, NY).

When I’m not working, I enjoy reading, crafting, live music and comedy, and espionage movies.